ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
BlackRockβs voting stake in ChemoMetec remains at 15.08%, following a shift to 100% direct share voting rights on 26 Oct.
Its position through financial instruments fell to 0%. The aggregate voting position is unchanged.
$CHEMM
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
BlackRockβs voting stake in ChemoMetec remains at 15.08%, following a shift to 100% direct share voting rights on 26 Oct.
Its position through financial instruments fell to 0%. The aggregate voting position is unchanged.
$CHEMM
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
Over the last 10 years, ChemoMetec has compounded its FCF at an exceptional CAGR of 44.29%.
When paired with a FCF linearity score of 0.91, this performance demonstrates consistency,highly predictable cash generation & a high quality business.
$CHEMM
Report on $ANT by .@NewConstructs π
Replying to @AnthropicAI
We crunched the numbers and @NewConstructs published a report on $ANT newconstructs.com/anthropic-β¦
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
Over the last 10 years, ChemoMetec has compounded its FCF at an exceptional CAGR of 44.29%.
When paired with a FCF linearity score of 0.91, this performance demonstrates consistency,highly predictable cash generation & a high quality business.
$CHEMM
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
BlackRock has reduced its direct voting rights in $CHEMM to 14.97%, falling below the 15% threshold. However, with an increase in financial instruments (0.11%), its aggregate voting position remains unchanged at 15.08%.
$CHEMM
Great businesses
- grow profitably,
- earn high returns on capital,
- convert those gains efficiently into free cash flow, and
- sustain all over decades.
A great business is not automatically a fortress business.
The distinction is important.
#QGARP
FinXers, here is another valuable piece of wisdom that .@long_equity shared with us π
There are three great opportunities in quality growth investing.
1. Low revenue growth companies with the potential for high FCF growth through significant margin expansion. E.g. $ICE $BR
2. High return on capital companies with the potential for high FCF growth through buybacks. $MSCI $FTNT $KLAC $LRCX
3. High FCF growth companies with the potential for a significant contraction in FCF yield (in other words, a re-rating). $MSCI $BR
I aim to have a portfolio where all three are in play.
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
$CHEMM will release Q1 2026/27 results on Nov 5, followed by an investor call on Nov 6.
Meanwhile, SEB raised its stock target price to DKK 580 (up from DKK 500) but maintained its Hold rating.
$CHEMM
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
$CHEMM has launched a DKK100M share buyback program running from Oct. 12, 2026, to March 5,2027. Managed by Danske Bank, the facility covers up to 500K shares, representing 2.9% of the share capital, to optimize the company's capital structureβ¬οΈ
$CHEMM
QGARP assesses quality, growth, allocation, resilience and predictability, then decides whether the valuation offers an acceptable return.
#QGARP
This is truly a must-read from .@NewConstructs π
Replying to @Barchart
Here's our full report with all to support our thesis. newconstructs.com/anthropic-β¦
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
$CHEMM has launched a DKK100M share buyback program running from Oct. 12, 2026, to March 5,2027. Managed by Danske Bank, the facility covers up to 500K shares, representing 2.9% of the share capital, to optimize the company's capital structureβ¬οΈ
$CHEMM
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
At today's AGM, ChemoMetec shareholders approved an authorization for the Board of Directors to acquire the company's shares, while voting to pass on a dividend for FY 2025/26 to support ongoing capital allocation strategy. β¬οΈ
$CHEMM
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
At today's AGM, ChemoMetec shareholders approved an authorization for the Board of Directors to acquire the company's shares, while voting to pass on a dividend for FY 2025/26 to support ongoing capital allocation strategy. β¬οΈ
$CHEMM
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
A quick look at ChemoMetec A/S $CHEMM , core financial profile and business overview via the latest Nasdaq Copenhagen and Morningstar factsheet.
$CHEMM
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
BlackRock has increased its voting stake in ChemoMetec to 15.08% on 29 Sept, crossing the 15% statutory threshold under the Danish Capital Markets Act. It was 13.03% on 28 Aug.
$CHEMM
NextVision Stabilized Systems Limited
$NXSN secures a US$24M purchase order for cameras & accessories from a client. Deliveries are scheduled to run from January through Q2 2027. The contract remains subject to pending regulatory approvals.
Link: investor-relations.nextvisioβ¦
$NXSN
NextVision Stabilized Systems Limited
NextVision secures US$3.5M purchase order for its cameras and accessories from a customer, with product delivery expected by the end of Q1 2027
Link: investor-relations.nextvisioβ¦
$NXSN
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
BlackRock has increased its voting stake in ChemoMetec to 15.08% on 29 Sept, crossing the 15% statutory threshold under the Danish Capital Markets Act. It was 13.03% on 28 Aug.
$CHEMM
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
ChemoMetec raised its financial guidance for fiscal year 2027 regarding revenue and EBITDA
Link: investor.chemometec.com/newsβ¦
$CHEMM
NextVision Stabilized Systems Limited
NextVision secures US$3.5M purchase order for its cameras and accessories from a customer, with product delivery expected by the end of Q1 2027
Link: investor-relations.nextvisioβ¦
$NXSN
NextVision Stabilized Systems Limited
Fidelity sells 5.7M shares of drone camera maker NextVision for $426M via Goldman Sachs, per Calcalistech - CTECH
Link: calcalistech.com/ctechnews/aβ¦
$NXSN
NextVision Stabilized Systems Limited
Fidelity sells 5.7M shares of drone camera maker NextVision for $426M via Goldman Sachs, per Calcalistech - CTECH
Link: calcalistech.com/ctechnews/aβ¦
$NXSN
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
ChemoMetec raised its financial guidance for fiscal year 2027 regarding revenue and EBITDA
Link: investor.chemometec.com/newsβ¦
$CHEMM
ChemoMetec A/S π©π°π¬π§ͺπ©βπ¬π§¬
Completion of share buyback programmeπ
$CHEMM































